Welcome to the December/January issue of Healthcare Sales and Marketing Magazine - featuring The Cleveland Clinic's Top 10 Innovations of 2017

• Report this article

Cari Kraft

Cari Kraft

Top 10% LinkedIn Recruiter, Medical Device Recruiter, Pharmaceutical Recruiter, Biotechnology Recruiter - ckraft@jacobsmgt.com; Career Igniter, Publisher HS&M

Published Dec 23, 2016

+ Follow

    

CHECK OUT THE NEW ISSUE OF HS&M: Taming The Tech Beast

Articles include: 

•  Executive Spotlight: Bayer, Lilly and Boehringer execs
• Roundtable: Taming the Tech Beast
• The Cleveland Clinic's Top Ten Advances for 2017
• The Office of the Future
• Great Minds: Mel Robbins
• Millennial Doctors Want More Contact
• Hear Directly from an HCP
• Broken Links: How to Get Analytics to Pay Off

Check out our regular features: By the Numbers and Motivideos

PLUS: Breaking news updated constantly

To view or add a comment, sign in

More articles by Cari Kraft

• AusperBio Secures $73M in Series B Funding to Advance Functional Cure for Chronic Hepatitis B... and more - Life Science Headlines January 2, 2025

  Jan 2, 2025

  AusperBio Secures $73M in Series B Funding to Advance Functional Cure for Chronic Hepatitis B... and more - Life Science Headlines January 2, 2025

  AusperBio Secures $73M in Series B Funding to Advance Functional Cure for Chronic Hepatitis B San Francisco, CA…

  8
• AbbVie to Acquire Nimble Therapeutics for $200M... and more - Life Science Headlines December 19, 2024

  Dec 19, 2024

  AbbVie to Acquire Nimble Therapeutics for $200M... and more - Life Science Headlines December 19, 2024

  AbbVie to Acquire Nimble Therapeutics for $200M, Expanding Autoimmune Pipeline and Peptide Innovation Platform North…

  15
• Novartis Bets $2.9B on PTC Therapeutics' Huntington’s Disease Drug Breakthrough... and more - Life Science Headlines December 5, 2024

  Dec 5, 2024

  Novartis Bets $2.9B on PTC Therapeutics' Huntington’s Disease Drug Breakthrough... and more - Life Science Headlines December 5, 2024

  Novartis Bets $2.9B on PTC Therapeutics' Huntington’s Disease Drug Breakthrough Warren, NJ, December 2, 2024 (Reuters)…

  4
• Boston Scientific Acquires Axonics for $3.7B to Expand Urology Portfolio... and more - Life Science Headlines November 21, 2024

  Nov 21, 2024

  Boston Scientific Acquires Axonics for $3.7B to Expand Urology Portfolio... and more - Life Science Headlines November 21, 2024

  Boston Scientific Acquires Axonics for $3.7B to Expand Urology Portfolio Marlborough, MA, November 15, 2024…

  5

  1 Comment
• AbbVie Acquires Aliada Therapeutics for $1.4B to Expand Alzheimer's Research Portfolio... and more - Life Science Headlines November 7, 2024

  Nov 7, 2024

  AbbVie Acquires Aliada Therapeutics for $1.4B to Expand Alzheimer's Research Portfolio... and more - Life Science Headlines November 7, 2024

  AbbVie Acquires Aliada Therapeutics for $1.4B to Expand Alzheimer's Research Portfolio North Chicago, IL, October 28…

  10

  1 Comment
• Seaport Therapeutics Secures $225M in Oversubscribed Series B Financing... and more - Life Science Headlines October 24, 2024

  Oct 24, 2024

  Seaport Therapeutics Secures $225M in Oversubscribed Series B Financing... and more - Life Science Headlines October 24, 2024

  Seaport Therapeutics Secures $225M in Oversubscribed Series B Financing to Propel Neuropsychiatric Drug Development…

  12
• Kailera Therapeutics raises $400M to advance next-generation obesity therapies... and more - Life Science Headlines October 10, 2024

  Oct 10, 2024

  Kailera Therapeutics raises $400M to advance next-generation obesity therapies... and more - Life Science Headlines October 10, 2024

  Kailera Therapeutics raises $400M to advance next-generation obesity therapies Boston, MA , October 1, 2024 (Globe…

  6
• Generate and Novartis enter $1B Collaboration to Develop AI-driven Protein Therapeutics... and more - Life Science Headlines September 26, 2024

  Sep 26, 2024

  Generate and Novartis enter $1B Collaboration to Develop AI-driven Protein Therapeutics... and more - Life Science Headlines September 26, 2024

  Generate and Novartis enter $1B Collaboration to Develop AI-driven Protein Therapeutics Somerville, MA, September 24…

  7
• Candid Therapeutics secures $370M to advance pioneering autoimmune therapies... and more - Life Science Headlines September 12, 2024

  Sep 12, 2024

  Candid Therapeutics secures $370M to advance pioneering autoimmune therapies... and more - Life Science Headlines September 12, 2024

  Candid Therapeutics secures $370M to advance pioneering autoimmune therapies with repositioned T-cell engagers San…

  9
• Johnson & Johnson Expands Heart Disease Device Portfolio with $1.7B V-Wave Deal ... and more - Life Science Headlines August 29, 2024

  Aug 29, 2024

  Johnson & Johnson Expands Heart Disease Device Portfolio with $1.7B V-Wave Deal ... and more - Life Science Headlines August 29, 2024

  Johnson & Johnson Expands Heart Disease Device Portfolio with $1.7B V-Wave Deal New Brunswick, NJ, August 20, 2024…

  11

  1 Comment

Show more

See all articles